Tempest Therapeutics, Inc.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Sep 2025 | Jun 2025 | Mar 2025 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-5.2M | $-27.7M | $-3.5M | $-7.9M | $-10.9M | $-10.6M | $-9.6M | $-7.9M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | $59.0K | $60.0K | $66.0K | $67.0K | $68.0K | $98.0K | $155.0K | $88.0K |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | — | — | — | — | — | — | — | — |
| Net Cash from Operating Activities | $-2.8M | $-7.6M | $-6.8M | $-8.4M | $-8.0M | $-10.2M | $-5.5M | $-7.2M |
| Investing Activities | ||||||||
| Capital Expenditures | $0 | $0 | $0 | $0 | $0 | $15.0K | $249.0K | $168.0K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | $0 | — | — | $0 | — | — | $-168.0K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | — | $1.7M | — | — | $-721.0K | — | — | $450.0K |
| Net Change in Cash | — | — | — | — | — | — | — | — |
| Free Cash Flow | $-2.8M | $-7.6M | $-6.8M | $-8.4M | $-8.0M | $-10.2M | $-5.8M | $-7.4M |